This proposal will continue the development and optimization of an innovative potential clinical treatment for asthma. Although there are a multitude of different possible triggers of an acute asthmatic attack, one defining feature of all such attacks is excessive contraction of the smooth muscle in the airway wall. Despite this common end point, most of the clinical asthma research and therapies in recent years have focused on understanding the immunologic factors that often lead to asthmatic attacks. Relatively little new research has focused directly on directly trying to limit this excessive smooth muscle contraction during an asthmatic attack. To this end, existing work supported by the current grant has already demonstrated the ability of this exciting new innovative method of treating the airway smooth muscle to permanently limit the ability of airway smooth muscle to shorten. This competitive renewal describes new objectives involving the optimization of the device that is used to deliver the RF energy to the smooth muscle, a procedure that is termed bronchial thermoplasty. It also involves new modeling and experimental work employing state of the art quantitative imaging to assess the effectiveness of these treatments in vivo. The project involves a close working partnership between the physiologic laboratories and expertise at the Johns Hopkins University and Asthmatx, Inc., the company that provides the mechanical and bioengineering skills involved in product development. The overall hypothesis governing this proposal is that, the treatment of airway smooth muscle with this innovative system will reduce asthma severity caused by smooth muscle contraction, regardless of the initiating stimulus for contraction. This approach has recently been validated in pilot study in 16 asthmatic subjects. In this proposal, three Specific Aims will be directed toward addressing this hypothesis.
The first aim will use mathematical modeling to ascertain how the radiofrequency (RF) treatment energy spreads in radial and axial directions along the airway tree.
The second aim will use the knowledge gained from this modeling to test new devices to deliver RF energy to the airway smooth muscle.
The third aim will determine the impact of clinically relevant physiologic changes on treatment effectiveness. The studies proposed in this BRP will thus allow optimization of a device that has the potential to effectively cure all forms of human asthma regardless of the etiology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL066020-09
Application #
7881503
Study Section
Special Emphasis Panel (ZRG1-RES-B (03))
Program Officer
Banks-Schlegel, Susan P
Project Start
2000-09-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
9
Fiscal Year
2010
Total Cost
$773,823
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Limjunyawong, Nathachit; Kearson, Alexandra; Das, Sandhya et al. (2015) Effect of point sampling density in quantifying mouse lung emphysema. Anat Rec (Hoboken) 298:531-7
Limjunyawong, Nathachit; Fallica, Jonathan; Horton, Maureen R et al. (2015) Measurement of the pressure-volume curve in mouse lungs. J Vis Exp :52376
Limjunyawong, Nathachit; Craig, John M; Lagassé, H A Daniel et al. (2015) Experimental progressive emphysema in BALB/cJ mice as a model for chronic alveolar destruction in humans. Am J Physiol Lung Cell Mol Physiol 309:L662-76
Paré, Peter D; Mitzner, Wayne (2012) Counterpoint: alterations in airway smooth muscle phenotype do not cause airway hyperresponsiveness in asthma. J Appl Physiol (1985) 113:839-42
Paré, Peter D; Mitzner, Wayne (2012) Airway-parenchymal interdependence. Compr Physiol 2:1921-35
Smaldone, Gerald C; Mitzner, Wayne (2012) Viewpoint: unresolved mysteries. J Appl Physiol (1985) 113:1945-7
Gunst, Susan J; Panettieri Jr, Reynold A (2012) Point: alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma. J Appl Physiol 113:837-9
Mitzner, Wayne; Sylvester, J T (2012) In memoriam Dr Solbert Permutt, 1925–2012. Eur Respir J 40:811-3
Mitzner, Wayne; Smaldone, Gerald (2012) Last word on viewpoint: unresolved mysteries. J Appl Physiol (1985) 113:1950
Paré, Peter D; Mitzner, Wayne (2012) Last Word on Counterpoint: Alterations in airway smooth muscle phenotype do not cause airway hyperresponsiveness in asthma. J Appl Physiol (1985) 113:848

Showing the most recent 10 out of 17 publications